Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1501 - 1525 of 2774 in total
Name Weight StructureDescriptionCategories
Indecainide308.4174

C20H24N2O
For the treatment of life-threatening dysrhythmias and sustained ventricular tachycardia.Not Available
Oxybuprocaine308.4158

C17H28N2O3
A local anesthetic used in ophthalmology.Anesthetics for Topical Use
Gestrinone308.4141

C21H24O2
Endometriosis with or without accompanying sterility. Treatment is limited to a single course of 6 months duration per lifetime [L1699, L1700].Antigonadotropins and Similar Agents
Phenylbutazone308.3743

C19H20N2O2
An NSAID used to treat backache and ankylosing spondylitis.Antiinflammatory Preparations, Non-Steroids for Topical Use / Butylpyrazolidines
Warfarin308.3279

C19H16O4
A vitamin K antagonist used to treat venous thromboembolism, pulmonary embolism, thromboembolism with atrial fibrillation, thromboembolism with cardiac valve replacement, and thromboembolic events post myocardial infarction.4-Hydroxycoumarins / Anticoagulants / Rodenticides / Vitamin K Antagonists
Nimesulide308.31

C13H12N2O5S
A cyclooxygenase 2 inhibitor used to treat acute pain and primary dysmenorrhea.Antiinflammatory Preparations, Non-Steroids for Topical Use
Tafamidis308.116

C14H7Cl2NO3
A medication used to treat transthyretin-mediated amyloidosis.Anti-Inflammatory Agents
Fingolimod307.4708

C19H33NO2
A sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19.Selective Immunosuppressants
Levobetaxolol307.434

C18H29NO3
Used in the treatment of open-angle glaucoma and ocular hypertension [FDA Label].Adrenergic Antagonists / Adrenergic beta-Antagonists / Agents causing hyperkalemia / Bradycardia-Causing Agents / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 Substrates
Benzatropine307.4293

C21H25NO
An anticholinergic drug used to treat Parkinson's disease (PD) and extrapyramidal symptoms, except tardive dyskinesia.Ethers of Tropine or Tropine Derivatives
Betaxolol307.4278

C18H29NO3
A cardioselective beta blocking agent commonly used to treat hypertension and elevated intraocular pressure (when administered ophthalmically).Beta Blocking Agents, Selective
Tolnaftate307.409

C19H17NOS
An antifungal agent used to treat various skin infections caused by fungi.Antifungal Agents / Naphthalenes / Thiocarbamates
Alcaftadine307.3895

C19H21N3O
A H1 histamine receptor antagonist for ophthalmic use to prevent itching associated with allergic conjunctivitis.Histamine H1 Antagonists
Zolpidem307.3895

C19H21N3O
A sedative hypnotic used for the short-term treatment of insomnia to improve sleep latency.GABA-A Receptor Agonists / gamma-Aminobutyric Acid-ergic Agonist / Pyridines / Sleep Aids, Pharmaceutical
Glutathione307.323

C10H17N3O6S
For nutritional supplementation, also for treating dietary shortage or imbalanceAntidotes
Nitazoxanide307.282

C12H9N3O5S
A thiazolide anti-infective used to treat infections by protozoa, helminths, anaerobic bacteria, microaerophilic bacteria, and viruses.Antiparasitic Agents / Antiprotozoals
Vadadustat306.7

C14H11ClN2O4
An oral hypoxia-inducible factor prolyl-hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis.Amino Acids / Amino Acids, Peptides, and Proteins / Antianemic Preparations / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (weak) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Erythropoiesis-Stimulating Agents / Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors / OAT3/SLC22A8 Inhibitors / OAT3/SLC22A8 Substrates / Pyridines / UGT1A1 Inducers / UGT1A1 Substrates / UGT1A9 Substrates / UGT2B7 substrates
Butacaine306.45

C18H30N2O2
Not AnnotatedAnesthetics, Local
Oxandrolone306.4397

C19H30O3
An androgenic hormone used to treat muscle loss from prolonged corticosteroid treatment and to treat bone pain associated with osteoporosis.Androstan Derivatives
Potassium citrate306.394

C6H5K3O7
An agent used to manage renal tubular acidosis, hypocitraturic calcium oxalate nephrolithiasis, and uric acid lithiasis with or without calcium stones.Calculi Dissolution Agent / Diuretics / Expectorants / Metabolic Alkalinizer / Potassium Salt
Ruxolitinib306.365

C17H18N6
A kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment.Agents for Dermatitis, Excluding Corticosteroids / Protein Kinase Inhibitors
Fluconazole306.2708

C13H12F2N6O
A triazole antifungal used to treat various fungal infections including candidiasis.Imidazole and Triazole Derivatives / Triazole and tetrazole derivatives / Triazole Derivatives
Sertraline306.23

C17H17Cl2N
A selective serotonin reuptake inhibitor (SSRI) indicated to treat major depressive disorder, social anxiety disorder and many other psychiatric conditions.Antidepressive Agents Indicated for Depression / Drugs causing inadvertant photosensitivity / Selective Serotonin Reuptake Inhibitors / Serotonin Modulators
Technetium Tc-99m medronate305.906

CH6O8P2Tc
A diagnostic radiopharmaceutical agent used as a bone imaging agent to delineate areas of altered osteogenesis.Technetium (99Mtc) Compounds
Fenoldopam305.756

C16H16ClNO3
A dopamine D1 receptor agonist used for the short term management of hypertension.Adrenergic and Dopaminergic Agents
Displaying drugs 1501 - 1525 of 2774 in total